Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)

Genes and Development

Volumn 13, Issue 22, 1999, Pages 3027-3033

  Sugimoto, Masataka ^a,b   Nakamura, Takeshi ^c   Ohtani, Naoko ^a   Hampson, Lynne ^d   Hampson, Ian N ^d   Shimamoto, Akira ^e   Furuichi, Yasuhiro ^e   Okumura, Ko ^b   Niwa, Shinichiro ^c   Taya, Yoichi ^f   Hara, Eiji ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SUMITOMO ELECTRIC INDUSTRIES LTD   (Japan)

^d ST MARY S HOSPITAL   (United Kingdom)

^e AGENE Research Institute   (Japan)

^f NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

CDK4; Cyclin D1; p16(INK4a)

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE; GENE PRODUCT; PROTEIN INHIBITOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; GENE ISOLATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD PHYSIOLOGY; CARRIER PROTEINS; CELL CYCLE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHROMOSOMES, HUMAN, PAIR 19; COS CELLS; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA, COMPLEMENTARY; ENZYME ACTIVATION; FIBROBLASTS; GENES; HELA CELLS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0032709473     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.22.3027     Document Type: Article

References (32)

1. INK4d. Nature 395: 244-250.
2. KIPI regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. 95: 1091-1096.
3. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583.
4. Dai, K., R. Kobayashi, and D. Beach. 1996. Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem. 271: 22030-22034.
5. Durfee, T., K. Becherer, P.-L. Cheng, S.-H. Yeh, Y. Yang, A.E. Kilburn, W.-H. Lee, and S.J. Elledge. 1993. The retinoblastoma protein associates with the protein phosphatase type I catalytic subunit. Genes & Dev. 7: 555-569.
6. Geng, Y., W. Whoriskey, M.Y. Park, R.T. Bronson, R.H. Meclema, L. Tiansen, R.A. Weinberg, and P. Sicinski. 1999. Rescue of cyclinD1 deficiency by knockin cyclinE. Cell 97: 767-777.
7. INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell. 7: 57-70.
8. DKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16: 859-867.
9. Hara, E., M. Hall, and G. Peters. 1997. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 16: 332-342.
10. Hirai, H., M.F. Roussel, J.-Y. Kato, R.A. Ashmun, and C.J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclinD-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15: 2672-2681.
11. Kato, J.-Y., H. Matsushime, S.W. Hiebert, M.E. Ewen, and C.J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Dev. 7: 331-342.
12. Kitagawa, M., H. Higashi, H.-K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J.-Y. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclinD1-Cdk4 is different from that for phosphorylation by cyclinA/E-Cdk2. EMBO J. 15: 7060-7069.
13. Koh, J., G.H. Enders, B.D. Dynlacht, and E. Harlow. 1995. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510.
14. LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for p21 family of CDK inhibitors. Genes & Dev. 11: 847-862.
15. Lamphere, L., F. Fiore, X. Xu, L. Brizuela, S. Keezer, C. Sardet, G.F. Draetta, and J. Gyuris. 1997. Interaction between Cdc37 and Cdk4 in human cells. Oncogene 14: 1999-2004.
16. Li, Y., C.W. Jenkins, M.A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261-2268.
17. Lukas, J., D. Parry, L. Aagaard, D. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375: 503-506.
18. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
19. INK4/MTSI tumor suppressor gene product. EMBO J. 14: 503-511.
20. Parry, D., D. Mahony, K. Wills, and E. Lees. 1999. CyclinD-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19: 1775-1783.
21. KIPI coordinate their inhibitory interactions with Cdk4 and Cdk2. Genes & Dev. 11: 492-503.
22. INK4a. Nature 395: 237-343.
23. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature 366: 704-707.
24. INK4a. Cell 88: 593-602.
25. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
26. 1-phase progression. Genes & Dev. 13: 1504-1412.
27. Stepanova, L., X. Leng, S.B. Parker, and J.W. Harper. 1996. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes & Dev. 10: 1491-1502.
28. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17: 5001-5014.
29. Swanton, C., D.J. Mann, B. Fleckenstein, F. Neipel, G. Peters, and N. Jones. 1997. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390: 184-187.
30. Tam, S.W., A.M. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogens 9: 2663-2674.
31. Thompson, F.H., M.A. Nelson, J.M. Trent, X.Y. Guan, Y. Liu, J.M. Yang, J. Emerson, L. Adair, J. Wymer, C. Balfour et al. 1996. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet. Cytogenet. 87: 55-62.
32. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.